In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1832 News Items found
DJ and MSK patient Cynthia Malaran performing joyfully at South Street Seaport
Quieting Cancer Anxiety With Music Therapy

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of the study at the annual meeting of the American Society of Cancer Oncology (ASCO), on June 1.
Article
Woman smiling with Central Park in the background.
New Drug Combination Improves Survival for ER+, HER2- Breast Cancer

Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers.
Bacillus Calmette-Guerin (BCG) vaccine
New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More Broadly

A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly.
Ask the Expert
Mammogram being given by radiology technician to patient.
Dense Breast Tissue and Cancer Risk: What You Should Know

Learn about dense breast tissue and what it means for your cancer risk and screening needs.
Man in his 70s (prostate cancer patient) smiling for camera
FDA Expands New Treatment for Metastatic Prostate Cancer: Targets a Protein Called PSMA

Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients.
A researcher working in an MSK lab
MSK Research Highlights, May 19, 2025

New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples.
GSK Graduates and MSK Leadership pose on the stage
MSK’s 2025 Convocation Inspires and Honors Achievement

At Memorial Sloan Kettering Cancer Center’s 46th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
Chrysothemis Brown
MSK Researchers Identify Key Player in Childhood Food Allergies: Thetis Cells

Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.
Dr. Rachel Grisham
FDA Approves Avutometinib-Defactinib Combination for Treating Recurrent Low-Grade Serous Ovarian Cancer With a KRAS Mutation

The FDA has approved the first-ever treatment developed for low-grade serous ovarian cancer, a rare type of ovarian cancer.
A lab coat with an MSK logo hangs on a hook
Meet the 2025 Graduates of the Gerstner Sloan Kettering Graduate School

Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.